^ 1.01.11.21.31.4Gormley, EA; Lightner, DJ; Faraday, M; Vasavada, SP. Diagnosis and Treatment of Overactive Bladder (Non-Neurogenic) in Adults: AUA/SUFU Guideline Amendment.. The Journal of urology. May 2015, 193 (5): 1572–80. PMID 25623739.
^ 2.02.12.22.3Gibbs, Ronald S. Danforth's obstetrics and gynecology 10. Philadelphia: Lippincott Williams & Wilkins. 2008: 890-891 [2016-06-13]. ISBN 9780781769372. (原始内容于2016-03-05).
^ 4.04.14.24.3Gormley, EA; Lightner, DJ; Burgio, KL; Chai, TC; Clemens, JQ; Culkin, DJ; Das, AK; Foster HE, Jr; Scarpero, HM; Tessier, CD; Vasavada, SP; American Urological, Association; Society of Urodynamics, Female Pelvic Medicine & Urogenital, Reconstruction. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline.. The Journal of urology. December 2012, 188 (6 Suppl): 2455–63. PMID 23098785.
^Urinary Bladder, Overactive. [1 June 2015]. (原始内容于2021-08-28).
^Ghosh, Amit K. Mayo Clinic internal medicine concise textbook. Rochester, MN: Mayo Clinic Scientific Press. 2008: 339 [2016-06-13]. ISBN 9781420067514. (原始内容于2016-03-05).
^Ruxton, K; Woodman, RJ; Mangoni, AA. Drugs with anticholinergic effects and cognitive impairment, falls and all-cause mortality in older adults: A systematic review and meta-analysis.. British journal of clinical pharmacology. 2 March 2015. PMID 25735839.
^Abrams, Paul. Overactive bladder syndrome and urinary incontinence. Oxford: Oxford University Press. 2011: 7-8 [2016-06-13]. ISBN 9780199599394. (原始内容于2016-03-05).
參見编辑
美國國家尿控協會(英语:National Association For Continence) (National Association For Continence (NAFC))
國際尿控學會(英语:International Continence Society) (International Continence Society (ICS))
Sacco E, Bientinesi R, Marangi F, D'Addessi A, Racioppi M, Gulino G, Pinto F, Totaro A, Bassi P. [Overactive bladder syndrome: the social and economic perspective]. Urologia. 2011, 78 (4): 241–56. PMID 22237808. doi:10.5301/RU.2011.8886(意大利语).
Cystitis & Overactive Bladder Foundation - UK (页面存档备份,存于互联网档案馆)